Novartis AG history, company profile (overivew) and corporate video

       Novartis AG is a multinational healthcare company headquartered in Basel, Switzerland.


    Innovative Medicines

       Innovative Medicines division is made up of two separate commercial organizations, Innovative Medicines International and Innovative Medicines US.

    Core therapeutic areas:

    • Cardiovascular
    • Hematology
    • Solid tumors
    • Immunology
    • Neuroscience
    • Ophthalmology
    • Respiratory


       Sandoz is one of the world’s largest companies in generic and biosimilar medicines.


       Novartis was formed in 1996 through the merger of Ciba-Geigy and Sandoz. The history of Novartis traces the converging histories of its three predecessor companies:


       Geigy’s origins date back to 1758 when Johann Rudolf Geigy-Gemuseus founded the chemicals and dyes trading company J.R. Geigy in Basel, Switzerland.


       Ciba’s origins date back to 1869 when Alexander Clavel began the production of fuchsine, a synthetic dye, in his silk dyeing factory in Basel, Switzerland.


       Sandoz’s origins date back to 1866 when Dr. Alfred Kern and Edouard Sandoz founded the chemical company Kern & Sandoz.

       In 2000, Syngenta was created in collaboration with AstraZeneca.

       In 2002, Novartis created the Novartis Institutes for BioMedical Research (NIBR), headquartered in Cambridge, Massachusetts, United States.

    - Advertisement -

       In 2006, Chiron Corporation was acquired.

       In 2007, the Gerber Products Company was sold to Nestlé.

       In 2011, Novartis acquired the medical laboratory diagnostics company Genoptix.

       In 2014, Novartis announced that it would acquire GlaxoSmithKline‘s cancer drug business as well as selling its vaccines business to GlaxoSmithKline.

       In 2019, Novartis announced an artificial intelligence cooperation with Microsoft.

       Novartis completed a series of transactions that focus the company on three main divisions: Pharmaceuticals, Alcon (eye care) and Sandoz (generic medicines).

       On April 2019, Alcon became a separately traded standalone company.

       In 2022, Novartis announced its intention to separate the Sandoz business as a standalone company.


    • Advanced Accelerator Applications (AAA) – is a Novartis company focused exclusively on radioligand therapy and precision imaging.
    • Gyroscope Therapeutics – is a clinical-stage gene therapy company focused on diseases of the eye.

       With more than 100,000 employees, Novartis AG is considered one of the largest pharmaceutical companies in the world. According to Forbes, it is considered one of the Largest Public Companies in the World.

    *Information from,, and

    **Video published on YouTube by “Novartis



    Related videos